Pfizer makes record $36Billion w No Reps or DTC

Quote
anonymous said:
My understanding is that they have to meet a set number of calls for Cologuard and one rep can’t do the reach and frequency required so I would think they would keep some from team 1 for coverage, I am speculating of course but it seems plausible.
Click to expand...
You are correct, pfizer is contractually committed to Exact and one rep can’t get it done. In hindsight the best move from a size standpoint would have been to keep C3 and sack C1, but that decision was made before tany went bust. Hate to see it but can’t say I’m surprised, tany was a crapshoot at best.
 




anonymous said:
You are correct, pfizer is contractually committed to Exact and one rep can’t get it done. In hindsight the best move from a size standpoint would have been to keep C3 and sack C1, but that decision was made before tany went bust. Hate to see it but can’t say I’m surprised, tany was a crapshoot at best.
Click to expand...
They could find reps to cover it from any division.
 












anonymous said:
We are talking about Cologard - it doesn't take much to promote it
Click to expand...
True, its a Cologard that is zero clinical or technical sell. This product easily can be sold by Publicis or 50k yr CSO with no insurance, 401k or benefit costs.
Or even sold by Virtual reps since the product has to be ordered & shipped anyway.
LMAO---Cologard, they didnt seriously put that down did they lol
 




anonymous said:
True, its a Cologard that is zero clinical or technical sell. This product easily can be sold by Publicis or 50k yr CSO with no insurance, 401k or benefit costs.
Or even sold by Virtual reps since the product has to be ordered & shipped anyway.
LMAO---Cologard, they didnt seriously put that down did they lol
Click to expand...

Can’t wait to come back and say I told you so when theses cuts affect everyone. Every division will be reduced and what you say is true about most products, it’s certainly not rocket science! If reps can make it to specialty sales with backgrounds in payroll, copier sales and rental car sales it’s not difficult to replace anyone.
 








anonymous said:
Fair point and vaccine div could pick it up… but then they would actually have to go out and make calls!
Click to expand...


True. But don't you find it hilarious that states are offering millions in lottery and other prizes to get the vax? As if a bunch of people are going to just forget about the risks and "go for the money". Or these articles that "society will reject you" if you don't get it. It's laughably bad. Never have I seen such a poorly orchestrated effort to convince people of something they should not take.
 




















anonymous said:
"service no-sale model". What a perfect description of the cluster we're heading towards.
Click to expand...
It's that elitist New York attitude towards the sales force. They think we are unnecessary and a cost to be managed, as well as a liability.

Well, we'll just see how many offices roll out the red carpet to talk about "disease state". And fumble around with an app. Most of the offices are wanting us to come back in for face to face appointments. The home office just believe what it wants to believe. Hive Mentality. Just like "everyone needs the vaccine". This is Waco 1993 all over again
 








I just don’t get it. It’s as if they forgot we have to compete in the marketplace. If you think these other companies are gonna follow our “lead” your crazy. They are actually driven and incentivized to win. I don’t think the shareholders who know what’s going on are gonna be ok with this. We are in the business of growing products and markets. I don’t think this new model does either.
Less incentive = less growth
Less growth = less revenue
Less revenue = less qtr results
Less qtr results = missed targets
Missed targets = lower stock $

Albert… Earth to Albert…

The windfall form the vaccine was a once in a lifetime gamble. And we gambled with a sure bet… the Fed govt with the panic of a perceived pandemic to approve anything for emergency use and the deep pockets to buy whatever we made at whatever the price.

They well will run dry… and when it does you will need to rely on the company portfolio to make revenue.

The same thing happened during the Lipitor years. It carried the company until it didn’t. Then the Toviaz, Exubra, PVC, neutered Chantix of the basement have to make it up and quick.
 




No one is going to follow our lead. No one.
But remember what Albert wants. He wants a small bio Pharma company. That’s where this is going. Besides the vaccine, I don’t see PFE with billion dollar products anymore. They will focus on small niches
 




What do you think an inside sales representative with broad virtual capabilities will actually do? Part-time or full time? If part time, will they get benefits? Will a sales rep 2.0 be the full time rep that works with the IAT? I think we may leave a lot of lower OD customers or customers not with an IDN to just access resources through the new galaxy portal. Definitely a transformation.
 




anonymous said:
What do you think an inside sales representative with broad virtual capabilities will actually do? Part-time or full time? If part time, will they get benefits? Will a sales rep 2.0 be the full time rep that works with the IAT? I think we may leave a lot of lower OD customers or customers not with an IDN to just access resources through the new galaxy portal. Definitely a transformation.
Click to expand...
Other companies are already doing this model post covid .
Virtual reps are contracted thru vendor like Publicis & are PT 20-30hrs wk but can reach more doctors PT than live reps do in 2wks.
Any resources needed or samples is an easy check computer box & send.
Any in depth clinical info then FMD request is made.
Any other requests then AM or KAM is requested for follow up.
It works awesome for other companies & decreases costs while increasing profit margins greatly.
Surprise Pfizer has not done this years ago
 




anonymous said:
I just don’t get it. It’s as if they forgot we have to compete in the marketplace. If you think these other companies are gonna follow our “lead” your crazy. They are actually driven and incentivized to win. I don’t think the shareholders who know what’s going on are gonna be ok with this. We are in the business of growing products and markets. I don’t think this new model does either.
Less incentive = less growth
Less growth = less revenue
Less revenue = less qtr results
Less qtr results = missed targets
Missed targets = lower stock $

Albert… Earth to Albert…

The windfall form the vaccine was a once in a lifetime gamble. And we gambled with a sure bet… the Fed govt with the panic of a perceived pandemic to approve anything for emergency use and the deep pockets to buy whatever we made at whatever the price.

They well will run dry… and when it does you will need to rely on the company portfolio to make revenue.

The same thing happened during the Lipitor years. It carried the company until it didn’t. Then the Toviaz, Exubra, PVC, neutered Chantix of the basement have to make it up and quick.
Click to expand...
You missed it . Pfizer has ALREADY done an 18 month pilot to see if profitable.
During covid all product reps stayed home and sales increase with large decrease in expenses . So the model has already been proven success for over a year half.
Reality- Pfe accidently discovered this model reaps greater profits due to not paying 150k per rep, 300k per 2rep terr, and 3k per rep monthly expense account.
Add it up and its TENS OF MILLIONS A MONTH SPENT THAT NOW WILL BE SAVED FOR BOTTOM LINE.

I hate it but its new realm of our industry morphing. All industries have went from live to virtual. Look at Insurance, Banking, etc
 




anonymous said:
Other companies are already doing this model post covid .
Virtual reps are contracted thru vendor like Publicis & are PT 20-30hrs wk but can reach more doctors PT than live reps do in 2wks.
Any resources needed or samples is an easy check computer box & send.
Any in depth clinical info then FMD request is made.
Any other requests then AM or KAM is requested for follow up.
It works awesome for other companies & decreases costs while increasing profit margins greatly.
Surprise Pfizer has not done this years ago
Click to expand...

name a pharma company that is doing this
 




Top Bottom
Back
Quote